home / stock / mltx / mltx quote
Last: | $41.255 |
---|---|
Change Percent: | 2.75% |
Open: | $40.03 |
Close: | $40.15 |
High: | $41.84 |
Low: | $39.91 |
Volume: | 49,705 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$41.255 | $40.03 | $40.15 | $41.84 | $39.91 | 49,705 | 07-03-2024 |
$40.15 | $41.6 | $40.15 | $42.15 | $39.995 | 379,417 | 07-02-2024 |
$41.8 | $43.68 | $41.8 | $45.76 | $41.1501 | 474,272 | 07-01-2024 |
$43.97 | $42.13 | $43.97 | $44.58 | $41.12 | 671,959 | 06-28-2024 |
$41.69 | $40.35 | $41.69 | $42.25 | $40.07 | 294,599 | 06-27-2024 |
$40.19 | $39.63 | $40.19 | $40.19 | $38.65 | 233,868 | 06-26-2024 |
$39.7 | $39.43 | $39.7 | $40.405 | $38.65 | 234,119 | 06-25-2024 |
$38.71 | $38.5 | $38.71 | $38.835 | $37.55 | 540,687 | 06-24-2024 |
$38.43 | $39.82 | $38.43 | $40.35 | $38.06 | 751,116 | 06-21-2024 |
$39.49 | $39.3 | $39.49 | $40.11 | $39.06 | 277,967 | 06-20-2024 |
$39.49 | $40.21 | $39.49 | $40.77 | $39.15 | 218,753 | 06-19-2024 |
$39.49 | $40.21 | $39.49 | $40.77 | $39.15 | 218,753 | 06-18-2024 |
$40.17 | $41.12 | $40.17 | $41.435 | $39.96 | 202,025 | 06-17-2024 |
$41.41 | $42.3 | $41.41 | $42.79 | $41.145 | 535,496 | 06-14-2024 |
$42.71 | $43.62 | $42.71 | $44.29 | $42.58 | 241,997 | 06-13-2024 |
$43.3 | $44 | $43.3 | $44.98 | $42.65 | 262,919 | 06-12-2024 |
$43.42 | $41.36 | $43.42 | $44 | $41.35 | 237,390 | 06-11-2024 |
$41.96 | $41.37 | $41.96 | $42.27 | $40.71 | 185,271 | 06-10-2024 |
$41.67 | $42.16 | $41.67 | $42.8 | $41.62 | 181,154 | 06-07-2024 |
$42.44 | $43.21 | $42.44 | $45 | $42 | 545,392 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
MoonLake Immunotherapeutics Company Name:
MLTX Stock Symbol:
NASDAQ Market:
MoonLake Immunotherapeutics Website:
2024-06-23 06:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ZUG, Switzerland, May 3, 2023 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has signed a collaboration agreement with SHL Medical,...
ZUG, Switzerland, April 19, 2023 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, will host today its Capital Markets Day for investors and analysts in New...